 Connection
Brian Freed to Cyclosporine
This is a "connection" page, showing publications Brian Freed has written about Cyclosporine.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.213 |
|
|
|
-
Freed BM, Bennett JA, Rosano TG, Brooks CA, Cramer SM, Lempert N. Assessment of the in vivo immunosuppressive activity of the major cyclosporine metabolite by leukemia allograft rejection. Transplantation. 1992 Feb; 53(2):456-60.
Score: 0.100
-
Kasten-Jolly J, Aubrey MT, Conti DJ, Rosano TG, Ross JS, Freed BM. Reversal of hyperglycemia in diabetic NOD mice by human proinsulin gene therapy. Transplant Proc. 1997 Jun; 29(4):2216-8.
Score: 0.036
-
Geiselhart L, Conti DJ, Freed BM. RO 31-8220, a novel protein kinase C inhibitor, inhibits early and late T cell activation events. Transplantation. 1996 Jun 15; 61(11):1637-42.
Score: 0.034
-
Gruber SA, Gallichio M, Rosano TG, Hughes SE, Singh TP, Lempert N, Conti DJ, Hasselbarth J, Freed BM, Stein D, Drusano G. Comparative pharmacokinetics of cyclosporine A and cyclosporine G in renal allograft recipients. Transplant Proc. 1996 Apr; 28(2):892.
Score: 0.033
-
Isenberg A, Singh TP, Shen GK, Freed BM, Conti DJ. Selective CellCept therapy in high-risk renal transplant recipients. Transplant Proc. 1998 Jun; 30(4):1188-9.
Score: 0.010
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|